Schistosomicidal and molluscicidal activities of aminoalkylamino substituted neo- and norneocryptolepine derivatives

References

• Alajarin M, Molina P, Vidal A. (1997). Formal total synthesis of the alkaloid cryptotackieine (neocryptolepine). J Nat Prod, 60, 747–748.
   Web of Science ®Google Scholar
• Bilharz T, Bir Beity Zur. (1852). Helminthology. Zsc f wiss Zoo, 4, 53–72.
   Google Scholar
• Botros S, Bennett J. (2007). Praziquantel resistance. Expert Opin Drug Discov, 2, 535–540.
   Web of Science ®Google Scholar
• Doenhoff MJ, Kusel JR, Coles GC, Cioli D. (2002). Resistance of Schistosoma mansoni to praziquantel: Is there a problem? Trans R Soc Trop Med Hyg, 96, 465–469.
   PubMed Web of Science ®Google Scholar
• Doenhoff MJ, Pica-Mattoccia L. (2006). Praziquantel for the treatment of schistosomiasis: Its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev Anti Infect Ther, 4, 199–210.
   PubMedGoogle Scholar
• El Sayed I, Van der Veken P, Steert K, Dhooghe L, Hostyn S, Van Baelen G, Lemière G, Maes BU, Cos P, Maes L, Joossens J, Haemers A, Pieters L, Augustyns K. (2009). Synthesis and antiplasmodial activity of aminoalkylamino-substituted neocryptolepine derivatives. J Med Chem, 52, 2979–2988.
   PubMed Web of Science ®Google Scholar
• Fenwick A, Webster JP. (2006). Schistosomiasis: Challenges for control, treatment and drug resistance. Curr Opin Infect Dis, 19, 577–582.
   PubMed Web of Science ®Google Scholar
• Gönnert R, Andrews P. (1977). Praziquantel, a new board-spectrum antischistosomal agent. Z Parasitenkd, 52, 129–150.
   PubMed Web of Science ®Google Scholar
• Ismail M, Botros S, Metwally A, William S, Farghally A, Tao LF, Day TA, Bennett JL. (1999). Resistance to praziquantel: Direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg, 60, 932–935.
   PubMed Web of Science ®Google Scholar
• Jonckers TH, van Miert S, Cimanga K, Bailly C, Colson P, De Pauw-Gillet MC, van den Heuvel H, Claeys M, Lemière F, Esmans EL, Rozenski J, Quirijnen L, Maes L, Dommisse R, Lemière GL, Vlietinck A, Pieters L. (2002). Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives. J Med Chem, 45, 3497–3508.
   PubMed Web of Science ®Google Scholar
• Kaczmarek L, Balicki R, Nantka-Namirski P, Peczynska-Czoch W, Mordarski M. (1988). Cancerostatics, VI. Synthesis and antineoplastic properties of some benzo-iso-alpha-carbolines. Arch Pharm (Weinheim), 321, 463–467.
   PubMed Web of Science ®Google Scholar
• Peczynska-Czoch W, Pognan F, Kaczmarek L, Boratynski J. (1994). Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: Novel cytotoxic, DNA topoisomerase II inhibitors. J Med Chem, 37, 3503–3510.
   PubMed Web of Science ®Google Scholar
• Pica-Mattoccia L, Cioli D. (2004). Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int j Parasitol, 34, 527–533.
   PubMed Web of Science ®Google Scholar
• Sheng Q, Hartwig FG. (2008). Amination of heteroaryl and aryl halide. Org Lett, 10, 4109–4112.
   PubMedGoogle Scholar
• Shi C, Zhang Q, Wang KK. (1999). Biradicals from thermolysis of N-[2-(1-alkynyl)phenyl]-N’-phenylcarbodiimides and their subsequent transformations to 6H-indolo[2,3-b]quinolines. J Org Chem, 64, 925–932.
   PubMed Web of Science ®Google Scholar
• Southgate VR, Rollinson D, Tchuem Tchuenté LA, Hagan P. (2005). Towards control of schistosomiasis in sub-Saharan Africa. J Helminthol, 79, 181–185.
   PubMed Web of Science ®Google Scholar
• Wright CW. (2007). Recent developments in naturally derived antimalarials: Cryptolepine analogues. J Pharm Pharmacol, 59, 899–904.
   PubMed Web of Science ®Google Scholar
• Wright CW. (2005). Plant derived antimalarial agents: New leads and challenges. Phytochem Rev, 4, 55–61.
   Google Scholar
• World Health Organization. (2002). Prevention and control of schistosomiasis and soil-transmitted helminthiasis. Report of a WHO Expert Committee. Geneva, Switzerland: World Health Organization.
   Google Scholar
• Ramirez B, Bickle Q, Yousif F, Mouries MA, Nwaka S.(2007). Schistosome challenge in compound screening. Exp Opin Drug Discov, 2, 1–9.
   PubMed Web of Science ®Google Scholar
• Yousif F, Hifnawy MS, Soliman G, Boulos L, Labib Th Mahmoud, S, Ramzy F, Yousif M, Hassan I, Mahmoud K,El- Hallouty SM, EL-Gendy M, Gohar L, EL-Manawaty M, EL-Menshawi BS. (2007).Large-scale in vitro screening of Egyptian native and cultivate plants for schistosomicidal activity. Pharm Biol, 45, 501–510.
   Web of Science ®Google Scholar
• Zim D, Buchwald SL. (2003). An air and thermally stable one- component catalyst for the amination of aryl chlorides. Org Lett, 5, 2413–2415.
   PubMed Web of Science ®Google Scholar